Published online October 26, 2009
PEDIATRICS Vol. 124 No. 5 November 2009, pp. 1447-1456 (doi:10.1542/peds.2009-0082)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Metry, D.
Right arrow Articles by Drolet, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metry, D.
Right arrow Articles by Drolet, B.
Related Collections
Right arrow Genetics & Dysmorphology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SPECIAL ARTICLE

Consensus Statement on Diagnostic Criteria for PHACE Syndrome

Denise Metry, MDa, Geoffrey Heyer, MDb, Christopher Hess, MDc, Maria Garzon, MDd, Anita Haggstrom, MDe, Peter Frommelt, MDf, Denise Adams, MDg, Dawn Siegel, MDh, Karla Hall, BSi, Julie Powell, MDj, Ilona Frieden, MDk,l and Beth Drolet, MDm

a Departments of Dermatology and Pediatrics, Baylor College of Medicine, Houston, Texas
b Nationwide Children's Hospital and Departments of Neurology and Pediatrics, Ohio State University, Cleveland, Ohio; Departments of
c Radiology
k Dermatology
l Pediatrics, University of California San Francisco, San Francisco, California
d Departments of Dermatology and Pediatrics, Columbia University, New York, New York
e Department of Dermatology, Indiana University, Bloomington, Indiana; Departments of
f Pediatrics
m Pediatric Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin
g Departments of Pediatrics and Oncology, University of Cincinnati, and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
h Department of Dermatology, Oregon Health and Science University, Portland, Oregon
i National Organization for Vascular Anomalies
j Department of Dermatology, Hospital St Justine, Montreal, Quebec, Canada

OBJECTIVES: A subgroup of patients with infantile hemangiomas have associated structural anomalies of the brain, cerebral vasculature, eyes, sternum, and/or aorta in the neurocutaneous disorder known as PHACE syndrome. The diagnosis has been broadly inclusive by using a case definition of a facial hemangioma plus ≥1 extracutaneous features, leading to numerous reports of potential associated disease features, many of uncertain significance. This consensus statement was thus developed to establish diagnostic criteria for PHACE syndrome.

METHODS: A multidisciplinary group of specialists with expertise in PHACE syndrome drafted initial diagnostic criteria on the basis of review of published, peer-reviewed medical literature and clinical experience. The group then convened in both executive and general sessions during the PHACE Syndrome Research Conference held in November 2008 for discussion and used a consensus method. All conflicting recommendations were subsequently reconciled via electronic communication and teleconferencing.

RESULTS: These criteria were stratified into 2 categories: (1) PHACE syndrome or (2) possible PHACE syndrome. Major and minor criteria were determined for the following organ systems: cerebrovascular, structural brain, cardiovascular, ocular, and ventral/midline. Definite PHACE requires the presence of a characteristic segmental hemangioma or hemangioma >5 cm on the face or scalp plus 1 major criterion or 2 minor criteria. Possible PHACE requires the presence of a hemangioma >5 cm on the face or scalp plus 1 minor criterion. The group recognized that it may be possible to have PHACE syndrome with a hemangioma affecting the neck, chest, or arm only or no cutaneous hemangioma at all. In such cases, fulfillment of additional required criteria would also lead to a possible PHACE diagnosis.

CONCLUSIONS: These criteria represent current knowledge and are expected to enhance future assessments of PHACE syndrome. It is understood that modifications are to be expected over time to incorporate new research findings.


Key Words: PHACE syndrome • PHACES syndrome • hemangioma • diagnostic criteria

Abbreviations: MRA—magnetic resonance angiography


Accepted Jun 5, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?